Doctors and the drug industry revisited

摘要

Is the ABPI code too restrictive? I ask this question because I never imagined it was, particularly when, several years ago with Richard Smith (who this month laments the failure of medical leadership over the MTAS issue: JRSM 2007;100:486), I edited a BMJ theme issue on the relationship between doctors and the pharmaceutical industry